Greenleaf Peter 4

What Happened
Peter Greenleaf, CEO of Aurinia Pharmaceuticals (AUPH), had 100,171 shares "disposed" on Feb 20, 2026 as shares withheld to satisfy tax withholding obligations tied to the vesting of restricted stock units. The shares are reported at $14.40 each, for a total value of approximately $1,442,462. This was a tax-withholding disposition upon RSU vesting, not an open-market sale.

Key Details

• Transaction date: 2026-02-20; Filing date (Form 4): 2026-02-23 — timely filed.
• Price reported: $14.40 per share. Total value of the withheld shares: $1,442,462.
• Shares withheld/disposed: 100,171. Reported as code F (tax withholding).
• Footnote: F1 — represents shares withheld to satisfy tax withholding upon RSU vesting.
• Shares owned after the transaction: Not specified in the provided filing excerpt (consult the full Form 4 for current holdings).

Context
Share-withholding to cover taxes is a common, routine disposition when restricted stock units vest and does not necessarily indicate a change in an insider’s view of the company. Because shares were withheld for taxes rather than sold on the open market, this transaction is administrative rather than a directional insider buy/sell signal. For full holdings and any additional related transactions, review the complete Form 4 on the SEC EDGAR site (Accession: 0001363683-26-000002).